Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
News Menu

News

News

Sun, Dec 16th, 2018
Americans Can Still Sign Up for 2019 Affordable Care Act Health Care Plans Today Despite Ruling on the ACA in Texas v United States

MOUNTAIN VIEW, Calif. , Dec. 15, 2018 /PRNewswire/ -- eHealth, Inc. (NASDAQ: EHTH) ( www.ehealth.com ) reminds consumers that open enrollment under the Affordable Care Act still runs through...

EHTH : 35.33 (-0.23%)
Stocks plunge to 8-month lows on growth fears; J&J nosedives

NEW YORK (AP) — Stocks staggered to eight-month lows Friday after weak economic data from China and Europe set off more worries about the global economy. Mounting tensions in Europe over Britain's impending...

SBUX : 65.34 (-2.35%)
PFE : 43.80 (-1.73%)
AMGN : 192.07 (-2.76%)
JNJ : 133.00 (-10.04%)
ADBE : 230.00 (-7.29%)
Spartan Motors Makes Donation to AL!VE Regional Community Health Park

SPAR : 7.18 (+0.42%)
Marizyme, Inc., Appoints New Members to its Board of Directors

FORT COLLINS, Colo. , Dec. 14, 2018 /PRNewswire/ --  Marizyme, Inc.  ("Marizyme" or the "Company"), a publicly traded (OTC:MRZM) company focusing on acquiring late-stage drug assets...

MRZM : 1.2500 (-3.10%)
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia

THOUSAND OAKS, Calif. , Dec. 14, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...

AMGN : 192.07 (-2.76%)
Statement on Reuters Talc Article

NEW BRUNSWICK, N.J. , Dec. 14, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today issued the following statement regarding speculation about the safety of our products.

JNJ : 133.00 (-10.04%)
INVESTOR ALERT: Ademi & O'Reilly, LLP Investigates Whether Johnson & Johnson (JNJ) Violated Securities Laws

MILWAUKEE , Dec. 14, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces an investigation of Johnson & Johnson (NYSE: JNJ) for possible violations of securities laws.

JNJ : 133.00 (-10.04%)
Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years

ABBOTT PARK, Ill., Dec. 14, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 32 cents per share, marking a 14 percent...

ABT : 70.76 (-1.97%)
U.S. News & World Report Features Medical Marijuana, Inc. CEO Discussing the Potential of Federal Legalization of Hemp and Marijuana

SAN DIEGO , Dec. 14, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered news...

MJNA : 0.0970 (+13.45%)
NW Bio Announces That UK Property Transaction Has Closed, Including Funding of Approximately $47.3 Million Gross Proceeds

BETHESDA, Md. , Dec. 14, 2018 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...

NWBO : 0.2666 (-9.32%)
Study Puts Aflac in Top 5 for Workplace Culture

COLUMBUS, Ga. , Dec. 14, 2018 /PRNewswire/ --  Aflac , the leader in voluntary insurance sales at U.S. worksites, is listed as a top five company in Comparably's  2018 list of the 50 Best...

AFL : 44.61 (-2.49%)
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman

BEIJING , Dec. 14, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) (" China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company...

CBPO : 72.02 (-6.50%)
Leap Therapeutics Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tract Cancer

CAMBRIDGE, Mass. , Dec. 14, 2018 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX) today presented clinical data from its ongoing Phase I/II study of TRX518 in combination with gemcitabine, KeytrudaÒ (pembrolizumab),...

LPTX : 2.91 (+1.39%)
TerrAscend Announces Agreement for US$75 Million Credit Facility

-   Credit facility to support initiation of TerrAscend's US acquisition strategy   -

TER : 32.51 (-1.48%)
TRSSF : 4.4500 (-0.07%)
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors

INDIANAPOLIS and SAN MATEO, Calif. , Dec. 14, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Evidation Health, a health and measurement company that helps innovative life sciences...

LLY : 111.93 (-2.55%)
MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders

CEDAR KNOLLS, N.J. , Dec. 14, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin...

LAND : 12.58 (+0.24%)
LDGYY : 17.4589 (unch)
MYOS : 1.50 (unch)
The Transformation Into a Company Focused on Clinical Development of Pharmaceuticals has now been Completed and Medivir Gives a Project Update

MVRBF : 5.1500 (+30.38%)
Symbility Securityholders Approve Plan of Arrangement with CoreLogic

TORONTO , Dec. 13, 2018 /PRNewswire/ - Symbility Solutions Inc. ("Symbility"), (TSXV: SY), a global software company focused on modernizing the insurance industry, announced that at a special meeting...

SY.VN : 0.610 (unch)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER , Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for...

EPIX : 2.47 (-2.37%)
EPI.VN : 3.600 (+16.13%)
Beleave Announces GMP Certification and Operational Updates

TORONTO , Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (" Beleave " or the " Company ") is pleased to announce that, following a detailed application and inspection...

BLEVF : 0.0801 (+6.80%)
BE : 14.12 (-1.94%)

Barchart Morning Call

Overnight Markets and NewsMar E-mini S&Ps (ESH19 -0.91%) this morning are down -0.80% and European stocks are down -0.87% on global growth concerns. Eurozone Dec manufacturing activity expanded at the slowest pace in 2-3/4 years and Eurozone Nov n... Read More

Chart of the Day

Getty Realty Corp (GTY)

The Barchart Chart of the Day belongs to Getty Realty (GTY) a REIT that holds gas stations, convenience stores and other transportation related real estate. I found the stock by sorting Barchart's Top Stocks to Own list first by the most frequen...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar